Literature DB >> 11680794

Parechoviruses, a novel group of human picornaviruses.

P Joki-Korpela1, T Hyypiä.   

Abstract

Parechoviruses are a recently established group of human viral pathogens. At the time of their first isolation, parechoviruses were classified among the enterovirus genus in the picornavirus family, but based on their different biological properties they were separated into their own genus. The type member is human parechovirus 1 (HPEV1), which frequently infects humans, in particular small children. The parechovirus genus also includes HPEV2 and the Ljungan virus, which was recently isolated from rodents, is a candidate for the group. Seroepidemiological studies have shown that the prevalence of HPEV1 antibodies is surprisingly high, exceeding 95% in adult populations. According to present data, HPEV1 causes mainly gastrointestinal and respiratory infections; however, severe disease conditions, such as myocarditis and encephalitis, have also been reported. HPEV2 infections appear to be rare, and it is currently not known whether the Ljungan virus can infect humans.

Entities:  

Mesh:

Year:  2001        PMID: 11680794     DOI: 10.3109/07853890109002095

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  34 in total

1.  Comparison of the NucliSens Basic kit (Nucleic Acid Sequence-Based Amplification) and the Argene Biosoft Enterovirus Consensus Reverse Transcription-PCR assays for rapid detection of enterovirus RNA in clinical specimens.

Authors:  Marie L Landry; Robin Garner; David Ferguson
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Rapid enterovirus RNA detection in clinical specimens by using nucleic acid sequence-based amplification.

Authors:  Marie L Landry; Robin Garner; David Ferguson
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

3.  Development, technical performance, and clinical evaluation of a NucliSens basic kit application for detection of enterovirus RNA in cerebrospinal fluid.

Authors:  Christine C Ginocchio; Frank Zhang; Amisha Malhotra; Ryhana Manji; Peter Sillekens; Helma Foolen; Marlieke Overdyk; Margot Peeters
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains.

Authors:  Mohammed Al-Sunaidi; Cigdem H Williams; Pamela J Hughes; David P Schnurr; Glyn Stanway
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

Review 5.  Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

Authors:  Diky Mudhakir; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

6.  Human parechovirus type 1, 3, 4, 5, and 6 detection in picornavirus cultures.

Authors:  Michel de Vries; Krzysztof Pyrc; Ron Berkhout; Wilma Vermeulen-Oost; Ronald Dijkman; Maarten F Jebbink; Sylvia Bruisten; Ben Berkhout; Lia van der Hoek
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

Review 7.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection.

Authors:  Eric J Buenz; Brian M Sauer; Reghann G Lafrance-Corey; Chandra Deb; Aleksandar Denic; Christopher L German; Charles L Howe
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

9.  Complete genome sequence of a novel human parechovirus.

Authors:  Chunmei Wang; Tongling Shan; Hao Zheng; Wu Tong; Fangzhou Chen; Han Hu; Qigai He; Guangzhi Tong
Journal:  J Virol       Date:  2012-11       Impact factor: 5.103

10.  Isolation and characterization of novel human parechovirus from clinical samples.

Authors:  Kanako Watanabe; Masayasu Oie; Masaya Higuchi; Makoto Nishikawa; Masahiro Fujii
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.